Clinical Trials on SARS Cov2, Immune Response in Taiwan
Total 12 results
-
Chimei Medical CenterCompletedReactive Axillary Lymphadenopathy for SARS-CoV-2 Vaccines in the Asian Taiwanese PopulationTaiwan
-
Chang Gung Memorial HospitalUnknownSepsis | Septic Shock | Severe Sepsis | Multiple Organ Failure | Systemic Inflammatory Response Syndrome (SIRS)Taiwan
-
Chang Gung Memorial HospitalUnknownSepsis | Septic Shock | Severe Sepsis | Multiple Organ Failure | Systemic Inflammatory Response Syndrome (SIRS)Taiwan
-
National Research Institute of Chinese Medicine...Recruiting
-
Senhwa Biosciences, Inc.Not yet recruitingCommunity-acquired Pneumonia | Influenza With Pneumonia | SARS-CoV-2 -Associated PneumoniaTaiwan
-
National Taiwan University HospitalCompletedCovid19 | SARS-CoV 2 InfectionTaiwan
-
Chang Gung Memorial HospitalCompletedPulmonary Tuberculosis | Genetic Variants of Host | Immune Response of HostTaiwan
-
National Taiwan University HospitalChang Gung Memorial Hospital; Kaohsiung Medical University Chung-Ho Memorial... and other collaboratorsCompletedEarly Syphilis | Serologic Response of Syphilis | High Risk BehaviorTaiwan
-
National Taiwan University HospitalCompletedHepatitis A | Human Immunodeficiency Virus | Vaccine Response ImpairedTaiwan
-
National Taiwan University HospitalCompletedHuman Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy ofTaiwan
-
National Taiwan University HospitalRecruitingHepatitis C Virus Infection | Hepatitis C Virus Infection, Response to Therapy of | Human Immunodeficiency Virus (HIV) CoinfectionTaiwan
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates